EyeWorld Weekly, February 23, 2024
➤ Study: artificial intelligence matches/outperforms ophthalmologists ➤ Primary endpoint met in Phase 3 trial using an antibody to treat thyroid eye disease ➤ FDA grants Breakthrough Device Designation to novel spectacle design ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, February 23, 2024
February 23, 2024
